Jan 8, 2026 04:05PM Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025

Oct 30, 2025 04:05PM Merit Medical Reports Third Quarter 2025 Results and Updates Full-Year Guidance

Oct 15, 2025 04:05PM Merit Medical to acquire C2 CryoBalloon technology for $22 million

Oct 15, 2025 04:05PM Merit Medical Signs Asset Purchase Agreement with PENTAX Medical to Acquire C2 CryoBalloon Technology

Jul 30, 2025 04:05PM Merit Medical Reports Second Quarter 2025 Results and Updates Full-Year Guidance

Jul 7, 2025 04:05PM Merit Medical names Martha Aronson as president and CEO

Jul 7, 2025 04:05PM Merit Medical Names Martha Aronson as New President and Chief Executive Officer

May 20, 2025 07:30AM Merit Medical Systems Inc. (MMSI) Acquires Biolife Delaware

May 20, 2025 07:30AM Merit Medical Acquires Biolife Delaware, L.L.C.

Apr 24, 2025 04:05PM Merit Medical Reports First Quarter 2025 Results and Updates Full-Year Guidance

Feb 25, 2025 04:05PM Merit Medical Reports Fourth Quarter and Full Year 2024 Results and Issues Fiscal Year 2025 Guidance

Jan 13, 2025 07:10PM Merit Medical Announces Preliminary Unaudited Revenue for the Year Ended December 31, 2024 and Plans to Announce Fourth Quarter and Year End 2024 Results and Issue Fiscal Year 2025 Guidance on Februar

Nov 1, 2024 09:15AM Merit Medical Completes Acquisition of Lead Management Portfolio from Cook Medical

Oct 30, 2024 04:05PM Merit Medical Reports Third Quarter 2024 Results and Raises Full-Year Guidance

Sep 17, 2024 07:03AM Merit Medical Systems Inc. (MMSI) to Purchase Lead Management Portfolio from Cook Medical

Sep 17, 2024 07:00AM Merit Medical Signs Agreement to Purchase Lead Management Portfolio from Cook Medical

Sep 16, 2024 08:30AM Merit Medical’s WRAPSODY WAVE Trial Demonstrates Superior Patency versus Standard of Care in AV Fistula Patients

Aug 1, 2024 04:10PM Merit Medical Reports Second Quarter 2024 Results and Raises Full-Year Guidance

Jul 1, 2024 09:15AM Merit Medical Systems Inc. (MMSI) Announces $105M Asset Purchase Agreement with EndoGastric Solutions

Jul 1, 2024 09:15AM Merit Medical Announces Asset Purchase Agreement with EndoGastric Solutions, Inc.® 

Apr 30, 2024 04:05PM Merit Medical Reports Results for First Quarter Ended March 31, 2024

Feb 28, 2024 04:05PM Merit Medical Reports Results For Fourth Quarter and Year Ended December 31, 2023 - Issues Fiscal Year 2024 Guidance

Feb 28, 2024 04:05PM Merit Medical Introduces “Continued Growth Initiatives” Program and Financial Targets for Three-Year Period Ending December 31, 2026

Jan 8, 2024 09:05AM Merit Medical Systems Inc. (MMSI) Announces Projected Preliminary Unaudited Revenue for the Year Ended December 31, 2023

Jan 8, 2024 09:00AM Merit Medical Announces Projected Preliminary Unaudited Revenue for the Year Ended December 31, 2023 and Plans to Announce Fourth Quarter and Year End 2023 Results and Issue Fiscal Year 2024 Guidance

Oct 26, 2023 04:05PM Merit Medical Reports Results for Third Quarter Ended September 30, 2023

Aug 3, 2023 09:25AM Merit Medical's (MMSI) WRAPSODY Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment

Aug 3, 2023 09:25AM Merit Medical’s WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment

Jul 25, 2023 04:05PM Merit Medical Reports Results For Second Quarter June 30, 2023

Jun 8, 2023 04:04PM Merit Medical (MMSI) Acquisition of Dialysis Catheter Portfolio and BioSentry Biopsy Tract Sealant System from AngioDynamics (ANGO) and Acquisition of Surfacer Inside-Out Access Catheter System from B

Jun 8, 2023 04:01PM Merit Medical Announces Acquisition of Dialysis Catheter Portfolio and the BioSentry® Biopsy Tract Sealant System from AngioDynamics, Inc. and Acquisition of the Surfacer® Inside-Out® Access Cathet

Apr 26, 2023 04:05PM Merit Medical Reports Results for First Quarter March 31, 2023

Feb 22, 2023 04:05PM Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2022 Issues Fiscal Year 2023 Guidance

Oct 26, 2022 04:05PM Merit Medical Reports Results for Quarter Ended September 30, 2022

Jul 27, 2022 04:15PM Merit Medical Reports Results for Quarter Ended June 30, 2022

Apr 27, 2022 04:05PM Merit Medical Reports Results for Quarter Ended March 31, 2022

Mar 7, 2022 09:25AM Merit Medical Systems Inc. (MMSI) Granted FDA Breakthrough Device Designation for Embosphere Microspheres

Mar 7, 2022 09:25AM Merit Medical Receives FDA “Breakthrough Device Designation” for Embosphere® Microspheres for Use in Genicular Artery Embolization for Symptomatic Knee Osteoarthritis

Feb 24, 2022 04:05PM Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2021, Issues FY 2022 Guidance

Nov 23, 2021 09:27AM Merit Medical Systems Inc. (MMSI) Announces Agreement in Principle to Settle Class Action Litigation

Nov 23, 2021 09:25AM Merit Medical Announces Agreement in Principle to Settle Class Action Litigation

Oct 28, 2021 04:05PM Merit Medical Reports Results For Quarter Ended September 30, 2021

Jul 29, 2021 04:05PM Merit Medical Reports Results for Quarter Ended June 30, 2021

Apr 29, 2021 04:05PM Merit Medical Reports Results for Quarter Ended March 31, 2021

Nov 14, 2019 08:35PM Bragar Eagel & Squire, P.C. Is Investigating Baxter International, Black Knight, Merit Medical Systems, and Forescout Technologies on Behalf of Stockholders and Encourages Investors to Contact the Fir